Mammalian homologs of these cell cycle regulators were subsequently isolated and by the mid-1990s a network of Cdk/cyclin complexes emerged opening a complete new field in cancer research since many of these cell cycle regulators are altered during oncogenesis and/or are potential therapeutic targets for cancer treatments [5]. This evidence concerns the gene RGCC and cancer.